Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Tamura A"'
Autor:
Masahiko Aoki, Shigenori Kadowaki, Naoki Takahashi, Takeshi Suzuki, Kotoe Oshima, Takayuki Ando, Yoshiyuki Yamamoto, Kentaro Kawakami, Yosuke Kito, Toshihiko Matsumoto, Keitaro Shimozaki, Yasuhiro Miyazaki, Toshifumi Yamaguchi, Michitaka Nagase, Takao Tamura, Yusuke Amanuma, Taito Esaki, Yuji Miura, Kohei Akiyoshi, Eishi Baba, Akitaka Makiyama, Yuji Negoro, Koji Nakashima, Naotoshi Sugimoto, Kengo Nagashima, Hirokazu Shoji, Narikazu Boku
Publikováno v:
Gastric Cancer. 26:132-144
Background Accelerated tumor growth during immunotherapy in pre-existing measurable lesions, hyperprogressive disease (HPD), has been reported. However, progression of non-measurable lesions and new lesions are frequently observed in patients with ad
Autor:
Kazushi Fukagawa, Yu Takahashi, Nobutake Yamamichi, Natsuko Kageyama-Yahara, Yoshiki Sakaguchi, Miho Obata, Rina Cho, Nobuyuki Sakuma, Sayaka Nagao, Yuko Miura, Naoki Tamura, Daisuke Ohki, Hiroya Mizutani, Seiichi Yakabi, Chihiro Minatsuki, Keiko Niimi, Yosuke Tsuji, Mitsue Yamamichi, Narumi Shigi, Shuta Tomida, Hiroyuki Abe, Tetsuo Ushiku, Kazuhiko Koike, Mitsuhiro Fujishiro
Publikováno v:
Gastric Cancer. 26:44-54
Gastric adenocarcinoma of fundic-gland type (GA-FG) is a gastric malignancy with little relation to Helicobacter pylori. Clinical characteristics of GA-FG have been established, but molecular mechanisms leading to tumorigenesis have not yet been eluc
Autor:
Li Yuan Bai, Yee Chao, Narikazu Boku, Taroh Satoh, Hyun Cheol Chung, Masahiro Tsuda, Won Ki Kang, Yoon-Koo Kang, Jae Yong Cho, Jen-Shi Chen, Ken Kato, Jong Gwang Kim, Yasuo Hamamoto, Keiko Minashi, Keun Wook Lee, Kun-Huei Yeh, Hiroki Sameshima, Keisho Chin, Sang Cheul Oh, Li-Tzong Chen, Kei Muro, Takaki Yoshikawa, Min Hee Ryu, Takao Tamura, Do Youn Oh, Satoshi Morita
Publikováno v:
Gastric Cancer
Background The phase 3 ATTRACTION-2 study demonstrated that nivolumab monotherapy was superior to placebo for patients with pretreated advanced gastric or gastroesophageal junction cancer, but early progression of tumors in some patients was of conce
Autor:
Li-Tzong Chen, Taroh Satoh, Keisho Chin, Takaki Yoshikawa, Yee Chao, Masahiro Tsuda, Hyun Cheol Chung, Keun Wook Lee, Keiko Minashi, Min Hee Ryu, Jong Gwang Kim, Yoon-Koo Kang, Jae Yong Cho, Ken Kato, Narikazu Boku, Won Ki Kang, Takao Tamura, Do Youn Oh, Kun-Huei Yeh, Li Yuan Bai, Yasuo Hamamoto, Taihei Nishiyama, Jen-Shi Chen, Kei Muro, Sang Cheul Oh
Publikováno v:
Gastric Cancer
Background ATTRACTION-2 demonstrated that nivolumab improved overall survival (OS) vs placebo in patients with advanced gastric cancer treated with ≥ 2 chemotherapy regimens. However, its long-term efficacy and outcome of treatment beyond progressi
Autor:
Y. Doki, C Ebisui, Atsushi Takeno, Shuichi Fukuda, Kentaro Kishi, Shuji Takiguchi, Tomoko Saito, Tsuyoshi Takahashi, Kazuyuki Okada, Hiroshi Imamura, Hiroki Fukunaga, O Takayama, Motohiro Hirao, Makoto Yamasaki, Noriko Matsuura, Jin Matsuyama, Shinichi Adachi, Hidetoshi Eguchi, Jyunya Fujita, Yusuke Akamaru, Yukinori Kurokawa, Tai Omori, Masahiko Yano, Shigeyuki Tamura, Ko Takachi, Kazumasa Fujitani, Takafumi Hirao, Koichi Demura
Publikováno v:
Gastric Cancer. 24:535-543
The appropriate surgical procedure for patients with upper third early gastric cancer is controversial. We compared total gastrectomy (TG) with proximal gastrectomy (PG) in this patient population. A multicenter, non-randomized trial was conducted, w
Autor:
Li-Tzong Chen, Hiroki Sameshima, Li Yuan Bai, Takao Tamura, Min Hee Ryu, Narikazu Boku, Do Youn Oh, Masahiro Tsuda, Keisho Chin, Yee Chao, Taroh Satoh, Keun Wook Lee, Takaki Yoshikawa, Keiko Minashi, Hyun Cheol Chung, Kun-Huei Yeh, Jae Yong Cho, Sang Cheul Oh, Jong Gwang Kim, Won Ki Kang, Ken Kato, Yasuo Hamamoto, Kei Muro, Yoon-Koo Kang, Jen-Shi Chen
Publikováno v:
Gastric Cancer. 23:510-519
Background Nivolumab showed improvement in overall survival (OS) in ATTRACTION-2, the first phase 3 study in patients with gastric/gastroesophageal junction (G/GEJ) cancer treated with ≥ 2 chemotherapy regimens. The 2-year follow-up results of ATTR
Autor:
Yuzo Matsushita, Eishi Baba, Yuji Negoro, Akira Nozaki, Shuichi Hironaka, Tomomi Kashiwada, Taito Esaki, Tatsuya Okuno, Hideki Shimodaira, Kazuhiro Yanagihara, Naotoshi Sugimoto, Masahide Ebi, Naohiro Okano, Mototsugu Shimokawa, Ichinosuke Hyodo, Hiroyuki Okuda, Akitaka Makiyama, Toshikazu Moriwaki, Takuya Honda, Narikazu Boku, Kei Muro, Takashi Tsuda, Akihito Tsuji, Shingo Tamura, Takeshi Kajiwara, Masaaki Noguchi, Junko Sugiyama, Shinya Ueda, Satoshi Otsu, Michitaka Nagase, Keiko Minashi, Koji Takeda, Takao Tamura, Daisuke Sakai, Kenji Kunieda
Publikováno v:
Gastric Cancer. 21:792-801
Background Fluoropyrimidine and platinum combination is the standard treatment for advanced or recurrent gastric cancer (AGC). However, fluoropyrimidine monotherapy is commonly used for elderly patients with AGC because of its good tolerability. Meth
Autor:
Taroh Satoh, Kenji Kunieda, Li-Tzong Chen, Naotoshi Sugimoto, Ken Kato, Sachio Fushida, Takako Eguchi Nakajima, Keisho Chin, Tomohiro Nishina, Kensei Yamaguchi, Masahiro Goto, Takaki Yoshikawa, Kei Muro, Masahiro Tsuda, Narikazu Boku, Keisei Taku, Kazuhiro Yoshida, Yoshito Komatsu, Keiko Minashi, Yasuo Iwamoto, Soh Saitoh, Takao Tamura, Taito Esaki, Hirofumi Fujii, Mizutomo Azuma, Eiji Oki, Yasushi Omuro, Yoon-Koo Kang, Yasuo Hamamoto, Nozomu Machida, Akihito Tsuji
Publikováno v:
Gastric Cancer
Background Nivolumab, an anti-programmed death-1 agent, showed survival benefits in Asian patients, including Japanese, with gastric/gastro-esophageal junction (G/GEJ) cancer. We report the analysis of the Japanese subpopulation from ATTRACTION-2 tha
Autor:
Takahiko Tamura, Kazune Fujisawa, Eri Munekage, Hiroyuki Kitagawa, Jun Iwabu, Nobuko Ishida, Sachi Tsuda, Hiromichi Maeda, Shigehiro Tsujii, Michiya Kobayashi, Sunao Uemura, Masaya Munekage, Tomoaki Yatabe, Kazuhiro Hanazaki, Tsutomu Namikawa
Publikováno v:
Gastric Cancer. 22:684-691
This study evaluated the prognostic value of alkaline phosphatase (ALP) and lactate dehydrogenase (LDH) together with host-related factors in patients with unresectable advanced gastric cancer. The study enrolled 262 patients who received chemotherap
Autor:
Atsushi Ohtsu, Michael Emig, Kumari Chandrawansa, Hirofumi Yasui, Yoshito Komatsu, Yasuhiro Shimada, Astra M. Liepa, Yasushi Omuro, Kohei Shitara, Tomohiro Nishina, Hansjochen Wilke, Toshihiko Doi, Kensei Yamaguchi, Kei Muro, Naotoshi Sugimoto, Yoshihiko Segawa, Shuichi Hironaka, Masahiro Gotoh, Seigo Yukisawa, Fumio Nagashima, Yukako Ichimiya, Takao Tamura, Taito Esaki
Publikováno v:
Gastric Cancer. 19:927-938
We evaluated the safety and efficacy of ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients previously treated for advanced gastric or gastroesophageal junction adenocarcinoma in Japanese and Western subgroups from the RAINBOW tria